Wednesday, January 25, 2017

US FDA News: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial

Injected particulate may result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or low-level allergic response to the particulate.
Read more: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial